Call for Papers - Special Issue: Emerging Practices in Therapeutic Targeting of Neurodegenerative Diseases by Modulating Protein Kinases Journal: Brain Research We invite researchers and experts to contribute to our upcoming special issue focused on innovative approaches in therapeutic targeting of neurodegenerative diseases through the modulation of protein kinases. Submissions exploring novel insights, experimental findings, and clinical applications are welcomed. More detail on topic and submission guidelines are provided below.. Co-Editor: Prof Belgin Sever #brainhealth #neuroscience #neurodegenerativediseases #médecine #pharmaceuticals #drugdiscovery #cellandgenetherapy #therapeutics #diagnostics #drugdevelopment https://lnkd.in/gPzDPCmF
Dr. Md. Imtaiyaz Hassan’s Post
More Relevant Posts
-
Delighted to share a new article titled "Role of MTH1 in Oxidative Stress and Therapeutic Targeting of Cancer" published today in the Redox Biology, a top tier journal of the field (#Impact factor 10.7). This #paper investigates a correlation of #oxidative stress and #tumor development with an emphasis to the #role of MTH1 #enzyme... Congratulations to Aaliya Taiyab, Dr. Anam Ashraf Mohd Nayab #cancerresearch #drugdiscovery #oxidativestress #research #Elsevier #publication #cancer #cell #molecule #protein #dna #gene
-
I am editing a book entitled Protein Kinase Inhibitors: The Promise of Natural Products in Cancer Therapeutics, to be published by Academic Press (Elsevier). This book will showcase the latest research and insights into utilizing natural products for cancer treatment through kinase inhibition. We invite eminent researchers in the fields of drug discovery and natural product-based cancer therapeutics to contribute chapters to this volume. For official invitations and chapter submissions, please contact us at hassanlab@jmi.ac.in. #CancerTherapeutics #NaturalProducts #KinaseInhibitors #DrugDiscovery #CancerResearch #Oncology #Biopharmaceuticals #TargetedTherapy #Pharmacology #MedicinalChemistry
-
Call for Papers: Special Issue on Emerging Practices in Therapeutic Targeting of Neurodegenerative Diseases by Modulating Protein Kinases Brain Research invites submissions for a special issue titled "Emerging Practices in Therapeutic Targeting of #Neurodegenerative Diseases by Modulating Protein Kinases." This issue will explore the latest research and innovations in leveraging protein kinases as therapeutic targets for neurodegenerative #diseases. Guest Editors: Dr. Md. Imtaiyaz Hassan, Jamia Millia Islamia Dr. Belgin Sever, Anadolu University Special Issue Focus: Neurodegenerative diseases, such as #Alzheimer's, #Parkinson's, and #Huntington's, represent a growing #public #health challenge, with effective treatment options still limited. #Protein kinases, which regulate numerous cellular pathways, have recently emerged as promising #therapeutic targets. This special issue aims to showcase the latest #advancements and novel strategies in modulating protein kinases to treat neurodegenerative diseases. We welcome original research articles, reviews, and perspectives covering the following topics: Identification and characterization of novel protein kinases involved in neurodegenerative diseases. Mechanistic insights into how protein kinases influence disease #pathogenesis and progression. Development and testing of small molecules, #peptides, or #biologics targeting protein kinases. Preclinical and #clinical studies on the therapeutic #potential of protein kinase modulation. #Pharmacological approaches and advanced #drug delivery systems targeting protein kinases. Combination #therapies involving protein kinases in neurodegenerative disease #treatment. #Manuscript Submission Information: We are currently accepting submissions. Please submit your manuscript via Brain Research #Editorial Manager, selecting the article type "VSI: Protein kinases." The submission deadline is October 31, 2024. All submissions should comply with Brain Research guidelines for manuscript formatting and ethical standards.
-
Excellent efforts of Chitra Dhiman and Bhoomika Sharma published in Nutrients MDPI #cancer #food #disease
I am pleased to announce the publication of my latest research, a narrative review examining the potential therapeutic role of plumbagin in the treatment of various cancers and metabolic disorders. This will facilitate the selection of appropriate treatment options for cancer patients, as the compound is naturally occurring and has a favorable side effect profile. I would like to express my gratitude to Dr. Md. Imtaiyaz Hassan sir for his guidance and support in this endeavor. The article is freely accessible via the following link: https://lnkd.in/g2QQs35Z #nutrients #plumbagin #cancer #cancertherapy #naturalproducts #antiinflammatory #anticancer #antioxidant #cardiovasculardiseases #neurodegenerativediseases #SARSCoV19
-
-
Another excellent international collaborative publication in the Cell Reports identifies SPTBN1 as a critical regulator of the functional phenotype of toxic aldehyde-induced MASH and a potential therapeutic target. Wonderful #Team #Efforts #Liver cancer, #toxic effect #drug target #cancer
National Post-Doctoral Fellow at All India Institute of Medical Sciences (AIIMS), New Delhi, INDIA
Excited to announce the publication of our research, “Aldehydes alter TGF-β signaling and induce obesity and cancer,” in #Cell Reports! This study was conducted over the past 8 years and our interpretation is that environmental toxins and diets can harness a master pathway like TGF-beta and hijack it to a pathological role in cancer and obesity. A heartfelt thank you to Dr. Lopa, Merinoff Endowed Chair and Co-Director at FIMR and CSHL, New York, for this remarkable collaboration. Dr. Md. Imtaiyaz Hassan The full text of the can be found here:
Aldehydes alter TGF-β signaling and induce obesity and cancer
cell.com
-
Delighted to share our latest publication in Ageing Research Reviews (Impact Factor 12.5) on the recent advancements in understanding #Alzheimer's disease. Our review offers a comprehensive analysis of the various risk factors and lifestyle-related conditions associated with AD, while also delving into the distinct subtypes of the disease, each with its unique pathophysiological mechanisms. We explore novel and precise drug targets that are closely linked to the neuropathology of these subtypes, paving the way for more targeted therapeutic interventions. This research has the potential to bring hope and optimism to the future of AD #treatment, significantly improving #patient outcomes. Congratulations to sneh prabha Professor Asimul Islam gulam hasan #AlzheimersDisease #Neuroscience #Research #DrugDevelopment #AgeingResearch #HealthcareInnovation The full story is available: https://lnkd.in/gqQaDiAi
Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics
sciencedirect.com
-
https://lnkd.in/gh2RxiWJ I am delighted to share the release of our edited book on #AI and COVID 19. This is a #multidisciplinary resource for those engaged in researching #COVID-19 and how emerging technologies are being used as tools for detection, transmission and treatment strategies. Special congratulations to the lead Editor Dr. Mohammad Sufian Badar Prof. Afshar Alam, Vice Chancellor, Jamia Hamdard, Dr. Jawed Ahmed and Prof. Nima REZAEI #Drug discovery #diagnosis #pandemic #vaccine #Artificial Intelligence
Teaching Faculty (Senior) at Department of Bioengineering, University of California, Riverside, CA, USA
It is with immense pleasure that I announce that my long pending book, "Diagnosis and Analysis of COVID-19 using Artificial Intelligence and Machine Learning-Based Techniques" has finally been published by Elsevier, USA. https://lnkd.in/gazJc4AG I am thankful to those who contributed the contents of the chapters and provide valuable feedback and suggestions. I am thankful to David K. Mills, PhD, Professor, Biological Science, Louisiana Tech University, Ruston, LA, USA, and Tommaso Dorigo, PhD, First Researcher @ INFN, Dipartimento di Fisica e Astronomia "G.Galilei", via Francesco, Marzolo 8, 35131 Padova, ITALY.
Diagnosis and Analysis of COVID-19 using Artificial Intelligence and Machine Learning-Based Techniques
shop.elsevier.com
-
https://lnkd.in/gh2RxiWJ Delighted to share the release of our edited book.... Heartiest congratulations to the lead Editor Dr. Mohammad Sufian Badar, Prof. Afshar Alam, Vice- Chancellor, Jamia Hamdard, Dr. Jawed Ahmad and Prof. Nima Razaei This is a multidisciplinary resource for those engaged in researching COVID-19 and how emerging technologies are being used as tools for detection, transmission and treatment strategies...
Teaching Faculty (Senior) at Department of Bioengineering, University of California, Riverside, CA, USA
It is with immense pleasure that I announce that my long pending book, "Diagnosis and Analysis of COVID-19 using Artificial Intelligence and Machine Learning-Based Techniques" has finally been published by Elsevier, USA. https://lnkd.in/gazJc4AG I am thankful to those who contributed the contents of the chapters and provide valuable feedback and suggestions. I am thankful to David K. Mills, PhD, Professor, Biological Science, Louisiana Tech University, Ruston, LA, USA, and Tommaso Dorigo, PhD, First Researcher @ INFN, Dipartimento di Fisica e Astronomia "G.Galilei", via Francesco, Marzolo 8, 35131 Padova, ITALY.
Diagnosis and Analysis of COVID-19 using Artificial Intelligence and Machine Learning-Based Techniques
shop.elsevier.com
-
The recent publication titled "Targeting prostate cancer via therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin" in the International Journal of Biological Macromolecules explores the potential of these natural compounds in inhibiting PIM-1 kinase, a protein involved in prostate cancer progression. The study highlights how Naringenin and Quercetin can disrupt key signaling pathways, thereby reducing cancer cell proliferation and survival. This approach offers a promising avenue for developing novel cancer therapies that specifically target PIM-1 kinase. Congratulations to Aanchal Rathi, Arunabh Chaudhury, Shaista Haider Aaliya Taiyab Professor Asimul Islam #Prostatecancer #cancerresearch #cancer #drug #naturalproduct #phytochemical #society Full paper is available here: https://lnkd.in/grxrfQBc
Targeting prostate cancer via therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin
sciencedirect.com
BioAnalytica AI | H-index: 20 | i-10: 31 | AI-Deep Learning | Lung Cancer | Multitargeted Drug Design | Molecular Enumeration | Drug Resistance | DFT | WaterMap | MD Simulation | FBDDS | ESMO | Editor-NPC, MRMC
10moCommenting for better reach 🎉✨